AnalytiCon Discovery, GmbH


Compounds


# Catalog Number IUPAC
301. NP-003468 4-(2,7-dihydroxy-6-methylheptan-2-yl)-3-hydroxybenzoic acid
302. NP-003469 1,6,8-trihydroxy-3-methyl-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid
303. NP-003472 1,11,22-trihydroxy-1,6,11,16,22,27-hexaazacyclodotriacontane-2,5,12,15,23,26-hexone
304. NP-003504 5,11,17,19-tetrahydroxy-15-methyl-2-oxapentacyclo[9.8.0.0¹,³.0⁴,⁹.0¹²,¹⁷]nonadeca-4,6,8-triene-10,13-dione
305. NP-003511 (3S,6R,6aS,7S)-6,6a,7,8-tetrahydroxy-3-methyl-1,2,3,4,5,6,6a,7,12,12a-decahydrotetraphene-1,12-dione
306. NP-003553 (1S,2S,5R,6R,7R,10S,12R,13R)-6,13-bis(hydroxymethyl)-2,6-dimethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecane-5,13-diol
307. NP-003571 7-acetyl-3,6-dihydroxy-8-methyl-1,2,3,4-tetrahydronaphthalen-1-one
308. NP-003579 (5Z)-3-aminonon-5-enoic acid
309. NP-003628 1-(3-acetyl-2,4,6-trihydroxyphenyl)ethan-1-one
310. NP-003660 2,3-dihydroxypropyl 13-methyltetradecanoate
311. NP-003742 (3S,6R,9S,12R,15S,18R)-3-(butan-2-yl)-4,10,16-trimethyl-6,9,12,15,18-pentakis(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
312. NP-003743 (3S,6R,9S,12R,15S,18R)-3-(butan-2-yl)-4,10,16-trimethyl-6-(2-methylpropyl)-9,12,15,18-tetrakis(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
313. NP-003750 3-chloro-4,6-dihydroxy-2-methyl-5-[(2E,4E)-3-methyl-5-[(1R,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]penta-2,4-dien-1-yl]benzaldehyde
314. NP-003800 3-acetyl-5-(butan-2-yl)-4-hydroxy-2,5-dihydro-1H-pyrrol-2-one
315. NP-003804 3-[(3S,6R,9S,12R,15S,18R,22S)-3-(butan-2-yl)-22-[(2R)-dodecan-2-yl]-18-[(1R)-1-hydroxyethyl]-6-[(4-hydroxyphenyl)methyl]-12,15-dimethyl-2,5,8,11,14,17,20-heptaoxo-1-oxa-4,7,10,13,16,19-hexaazacyclodocosan-9-yl]propanamide
316. NP-003874 (2R,3R,4S,6S)-6-{[(2R,3S,4R)-6-{[(2R,3R,4R,6S)-6-{[(2S,3S)-6-{[(2S,4R,5R,6R)-5-(acetyloxy)-4-{[(2S,4R,5S,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-8,9-dihydroxy-7-methyl-1-oxo-1,2,3,4-tetrahydroanthracen-2-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl acetate
317. NP-003886 3-hydroxy-1-oxo-1-[(2,3,4,5,6-pentahydroxyhexyl)oxy]decan-5-yl 3,5-dihydroxydecanoate
318. NP-003939 (9Z,12Z)-6,8-dihydroxyoctadeca-9,12-dienoic acid
319. NP-003940 (3S)-8-hydroxy-3-methyl-1,2,3,4,7,12-hexahydrotetraphene-1,7,12-trione
320. NP-003952 (1S,6R,11aR,13R,14aS)-1,13-dihydroxy-6-methyl-1H,4H,6H,7H,8H,9H,11aH,12H,13H,14H,14aH-cyclopenta[f]oxacyclotridecan-4-one
321. NP-003955 (1R)-1-[(1R,2R,10R,11S,12S)-5-[(1R,2R,10R,11S,12S)-11-[1-(acetyloxy)ethyl]-2,4,12-trihydroxy-12-methyl-9,14-dioxo-15-oxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-5-yl]-2,4,12-trihydroxy-12-methyl-9,14-dioxo-15-oxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-11-yl]ethyl acetate
322. NP-003957 (1R)-1-[(1R,2R,10R,11S,12S)-5-(5-acetyl-1,8-dihydroxy-6-methyl-9,10-dioxo-9,10-dihydroanthracen-2-yl)-2,4,12-trihydroxy-12-methyl-9,14-dioxo-15-oxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-11-yl]ethyl acetate
323. NP-003960 2,4-dihydroxy-6-methyl-3-[(2E,4E)-3-methyl-5-[(1R,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]penta-2,4-dien-1-yl]benzaldehyde
324. NP-003962 6-[(1R)-1-hydroxypentyl]-4-methoxy-2H-pyran-2-one
325. NP-004037 methyl 7-(acetyloxy)-9a-formyl-2-hydroxy-2,3b,6,6,11,11a-hexamethyl-1,3-dioxo-1H,2H,3H,3aH,3bH,4H,5H,5aH,6H,7H,8H,9H,9aH,9bH,11aH-cyclopenta[a]phenanthrene-3a-carboxylate
326. NP-004047 3-[(3,5-dihydroxydecanoyl)oxy]-5-hydroxydecanoic acid
327. NP-004128 3-{3-[3,4-dihydroxy-5-(6-hydroxy-9H-purin-9-yl)oxolan-2-yl]propanoyl}benzoic acid
328. NP-004144 3-benzyl-4-phenyl-2,5-dihydrofuran-2-one
329. NP-004194 3,5-dihydroxydecanoic acid
330. NP-004271 N-(3-{14,17-bis[3-(N-hydroxyacetamido)propyl]-8-(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexaazacyclooctadecan-2-yl}propyl)-N-hydroxyacetamide
331. NP-004466 3-[3,13,19-tris(carbamoylmethyl)-6-(hydroxymethyl)-16-[(4-hydroxyphenyl)methyl]-1,4,7,11,14,17,20,23-octaoxo-9-undecyl-hexacosahydro-1H-pyrrolo[2,1-i]1,4,7,10,13,16,19,22-octaazacyclopentacosan-22-yl]propanamide
332. NP-004467 4,5-dihydroxy-3-propylcyclopent-2-en-1-one
333. NP-004527 1,3,6-trihydroxy-8-methyl-9H-xanthen-9-one
334. NP-004604 5,6,8-trihydroxy-2-methyl-9-{5,6,8-trihydroxy-2-methyl-4-oxo-2H,3H,4H-naphtho[2,3-b]pyran-9-yl}-2H,3H,4H-naphtho[2,3-b]pyran-4-one
335. NP-004663 (4R,4aS,8aS)-4-formyl-4-hydroxy-3,4a,8,8-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl (2E,4E,6E)-octa-2,4,6-trienoate
336. NP-004713 (4S,4aR)-4-(hydroxymethyl)-3,4a,8,8-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-one
337. NP-004769 3,7,8-trihydroxy-3-methyl-10-oxo-1H,3H,4H,10H-pyrano[4,3-b]chromene-9-carboxylic acid
338. NP-004779 3,4-dihydroxy-4-(4-methoxyphenyl)-1,2,3,4-tetrahydroquinolin-2-one
339. NP-004800 (6Z)-14-methylpentadec-6-enoic acid
340. NP-004811 (4S,5S,6E,8S,10R)-4,5,8-trihydroxy-10-methyl-3,4,5,8,9,10-hexahydro-2H-oxecin-2-one
341. NP-004844 (1'R,2'R,3'S,10'R)-3',10'-dihydroxy-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-4'-one
342. NP-004865 4,5-dihydroxy-9,10-dioxo-3-propyl-9,10-dihydroanthracene-2-carboxylic acid
343. NP-004987 8-hydroxy-4-(2-hydroxypropan-2-yl)-10-oxatricyclo[7.2.1.0¹,⁵]dodec-3-ene-8-carboxylic acid
344. NP-004993 2-[(2-aminophenyl)formamido]propanoic acid
345. NP-005003 12-[hydroxy(4-hydroxyphenyl)methyl]-18-[(1H-indol-3-yl)methyl]-6-(propan-2-yl)-docosahydro-1H-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosane-1,4,7,10,13,16,19-heptone
346. NP-005089 (2E,4E)-6-{[(5R,9aS,9bS)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-1H,3H,5H,5aH,6H,7H,8H,9H,9aH,9bH-naphtho[1,2-c]furan-5-yl]oxy}-6-oxohexa-2,4-dienoic acid
347. NP-005136 5-[(1E)-3-hydroxy-3-methylbut-1-en-1-yl]-2-methylcyclohex-5-ene-1,2,4-triol
348. NP-005175 (2R,3E)-2-hydroxy-N-[(2S,3R,4E,8E)-3-hydroxy-9-methyl-1-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadec-3-enamide
349. NP-005176 (2R)-2-hydroxy-N-[(2S,3R,4E,8E)-3-hydroxy-9-methyl-1-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]octadecanamide
350. NP-005192 [(5aS,6S,7aR,8R,9S,11aS,11bS,12R)-6,9-bis(acetyloxy)-12-hydroxy-5a,8,11a-trimethyl-1-oxo-3-(pyridin-3-yl)-1,5a,6,7,7a,8,9,10,11,11a,11b,12-dodecahydro-2,5-dioxatetraphen-8-yl]methyl acetate


 
2020 MolPort, v3.9, release date 08-09-2020 15:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.